Roche sales slide as COVID boost fades away
Roche's quarterly sales declined 6% as a slump in COVID treatments and diagnostic testing outweighed gains from hemophilia and multiple sclerosis treatments.
Subscribe to:
Post Comments (Atom)
Comments
Post a Comment
Leave a comment. Thanks!
Comentarios de Facebook